Benchmark Electronics Inc.: Q3 FY2025 earnings call
What management said about Q3 FY2025, from the documents filed with the SEC on 4 November 2025: press release. Guidance figures: 5 new. The quarter’s numbers.
Key takeaways
- Revenue grew 3.5% year over year: Revenue was $681 million, up from $658 million a year earlier and $642 million in the June quarter. Source
- Diluted EPS rose from prior quarter: GAAP diluted EPS was $0.39, against $0.03 in the June quarter and $0.42 a year earlier. Non-GAAP diluted EPS was $0.62, against $0.55 and $0.57. Source
- A&D and Medical grew most: A&D revenue was $129 million, up from $102 million a year earlier. Medical was $126 million, up from $107 million. Source
- Bookings momentum continued in quarter: Management said bookings momentum continued in the third quarter, reinforcing the strength seen earlier in the year. Source
- Non-GAAP operating margin rose: Non-GAAP operating margin was 4.8%, up from 4.7% in the June quarter and down from 5.3% a year earlier. Source
- Operating cash flow turned positive: Operating cash flow was $36.6 million in the quarter, against negative $2.8 million in the June quarter. Free cash flow was $25.1 million. Source
“During the quarter we saw improved year-over-year performance across the majority of our market sectors and I am encouraged by indicators pointing to stronger growth as we exit the year”
Jeff Benck, Benchmark’s CEO
Guidance
| Area | Period | Figure | Against last quarter |
|---|---|---|---|
| Revenue Source | Fourth quarter 2025 | $670 million - $720 million | New |
| Diluted GAAP earnings per share Source | Fourth quarter 2025 | $0.44 - $0.50 | New |
| Diluted non-GAAP earnings per share Source | Fourth quarter 2025 | $0.62 - $0.68 | New |
| Stock-based compensation excluded from non-GAAP EPS Source | Fourth quarter 2025 | approximately $2.3 million | New |
| Other non-operating expenses excluded from non-GAAP EPS Source | Fourth quarter 2025 | $4.9 million to $5.3 million | New |
What changed from last quarter
- New guidance: Fourth quarter 2025 guidance was given in this release; the previous release gave third quarter 2025 guidance. Source
- New: Enterprise AI opportunities described as in the beginning stages of ramping; the previous release did not mention them. Source
Results and growth drivers
- Revenue grew 3.5% year over year: Revenue was $681 million, up from $658 million a year earlier and $642 million in the June quarter. Source
- Diluted EPS rose from prior quarter: GAAP diluted EPS was $0.39, against $0.03 in the June quarter and $0.42 a year earlier. Non-GAAP diluted EPS was $0.62, against $0.55 and $0.57. Source
- Non-GAAP operating income rose sequentially: Non-GAAP income from operations was $32.6 million, up from $30.1 million in the June quarter and down from $34.9 million a year earlier. Source
- Nine-month net income fell: Nine-month GAAP net income was $18.9 million against $44.9 million. Nine-month income tax expense was $26.7 million against $15.1 million. Source
Segments and end markets
- A&D and Medical grew most: A&D revenue was $129 million, up from $102 million a year earlier. Medical was $126 million, up from $107 million. Source
- AC&C rose from June quarter: AC&C revenue was $88 million, up from $74 million in the June quarter and down from $110 million a year earlier. Source
- Semi-Cap little changed year over year: Semi-Cap revenue was $185 million, down from $188 million a year earlier and $190 million in the June quarter. Its share of revenue was 27%. Source
- Industrial near prior-year level: Industrial revenue was $153 million, up from $151 million a year earlier and $142 million in the June quarter. Source
“Our bookings momentum continued in the third quarter of 2025, reinforcing the strength we’ve seen all year.”
David Moezidis, President and Chief Commercial Officer
Demand and bookings
- Bookings momentum continued in quarter: Management said bookings momentum continued in the third quarter, reinforcing the strength seen earlier in the year. Source
- Enterprise AI ramp in beginning stages: Management described enterprise AI as in the beginning stages of ramping, as an indicator of growth as the year ends. Source
- Year-over-year gains in most sectors: Management said performance improved year over year across most market sectors during the quarter. Source
Margins
- Non-GAAP operating margin rose: Non-GAAP operating margin was 4.8%, up from 4.7% in the June quarter and down from 5.3% a year earlier. Source
- GAAP operating margin rose: GAAP operating margin was 3.5%, up from 3.2% in the June quarter and down from 4.3% a year earlier. Source
- Gross margin nearly unchanged: GAAP gross margin was 10.0%, against 10.1% in the June quarter and 10.1% a year earlier. Source
Costs and operating expenses
- GAAP SG&A rose on quarter: GAAP selling, general and administrative expenses were $41.5 million, up from $40.6 million in the June quarter and $36.6 million a year earlier. Source
- Stock-based compensation rose: Stock-based compensation expense was $5.3 million in the quarter, against $4.4 million a year earlier. Nine-month expense was $15.1 million against $10.7 million. Source
- Mexico tax settlement in legal line: Legal and other settlement loss was $0.8 million in the quarter and $11.9 million for nine months, including a Mexico tax assessment settlement. Source
Cash flow and working capital
- Operating cash flow turned positive: Operating cash flow was $36.6 million in the quarter, against negative $2.8 million in the June quarter. Free cash flow was $25.1 million. Source
- Nine-month free cash flow lower: Nine-month free cash flow was $37.3 million against $119.1 million a year earlier. Nine-month capital expenditures were $28.0 million against $24.2 million. Source
- Cash conversion cycle shortened: Cash conversion cycle was 77 days, against 85 days in the June quarter and 90 days a year earlier. Inventory days fell to 75 from 83. Source
Capital and balance sheet
- Share repurchases rose in nine months: Nine-month share repurchases were $26.0 million, against $5.1 million a year earlier. Net debt activity was a $41.4 million outflow. Source
- Cash and debt balances declined: Cash and cash equivalents were $285.4 million at September 30, 2025, against $315.2 million at December 31, 2024. Long-term debt was $212.6 million, against $250.5 million. Source
- Equity slightly lower: Shareholders’ equity was $1,109.3 million, against $1,113.3 million at December 31, 2024. Total assets were $2,067.3 million. Source
Coming up, as management said on 4 November 2025
- Growth expected into 2026: Management said the bookings trend positions the company for continued growth as it looks to 2026 and beyond. Source
Figures management reported
| Figure | Reported |
|---|---|
| Semi-Cap revenue Source | $185 million, 27% of revenue |
| Industrial revenue Source | $153 million, 22% of revenue |
| A&D revenue Source | $129 million, 19% of revenue |
| Medical revenue Source | $126 million, 19% of revenue |
| AC&C revenue Source | $88 million, 13% of revenue |
| Gross margin, GAAP Source | 10.0% |
| Gross margin, non-GAAP Source | 10.1% |
| Days in inventory Source | 75 |
| Days in cash conversion cycle Source | 77 |
Risks management discussed
- Financial: Discrete tax charges of $0.8 million in the quarter and $11.3 million for nine months relate to foreign withholding tax and deferred tax on China unremitted earnings. Source
- Operational: Restructuring charges and other costs of $1.2 million in the quarter were excluded from non-GAAP results. Source
Earlier plans management reported on
- Met: Management said the company achieved the high end of its guidance range for revenue and non-GAAP EPS in the third quarter. Source
Other quarters
Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.